UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000031125
Receipt number R000035554
Scientific Title Heparin and coagulation factor levels of the cell saver and cardiopulmonary bypass blood
Date of disclosure of the study information 2018/02/21
Last modified on 2020/01/28 13:03:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Heparin and coagulation factor levels of the cell saver and cardiopulmonary bypass blood

Acronym

Heparin and coagulation factor levels of the cell saver and cardiopulmonary bypass blood

Scientific Title

Heparin and coagulation factor levels of the cell saver and cardiopulmonary bypass blood

Scientific Title:Acronym

Heparin and coagulation factor levels of the cell saver and cardiopulmonary bypass blood

Region

Japan


Condition

Condition

cardiac surgery cases

Classification by specialty

Anesthesiology Cardiovascular surgery Blood transfusion

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

heparin concentration in cell saver blood

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

heparin concentration in cell saver blood

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >

Gender

Male and Female

Key inclusion criteria

all cases of cardiac surgery with cell saver

Key exclusion criteria

none

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Tamura
Middle name
Last name Takahiro

Organization

Nagoya University Graduate School of Medicine

Division name

Department of Anesthesiology

Zip code

466-8550

Address

Nagoya

TEL

052-741-2111

Email

takahiro@med.nagoya-u.ac.jp


Public contact

Name of contact person

1st name Tamura
Middle name
Last name Takahiro

Organization

Nagoya University Graduate School of Medicine

Division name

Department of Anesthesiology

Zip code

466-8550

Address

Nagoya

TEL

052-741-2111

Homepage URL


Email

takahiro@med.nagoya-u.ac.jp


Sponsor or person

Institute

Nagoya University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Nagoya University Graduate School of Medicine

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

IRB, Nagoya University hospital

Address

Nagoya

Tel

+81527412111

Email

takahiro@med.nagoya-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 02 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 02 Month 03 Day

Date of IRB

2019 Year 06 Month 04 Day

Anticipated trial start date

2018 Year 06 Month 04 Day

Last follow-up date

2019 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This study is to check again about concentration of heparin in cell saver blood. And we will check coagulation test of blood as INR, APTT, Fibrinogen as well.


Management information

Registered date

2018 Year 02 Month 03 Day

Last modified on

2020 Year 01 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035554


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name